Case Study
Change Grow Live adopts fingerprint drug test across 50 sites to reduce Coronavirus risk
Change Grow Live, the UK’s leading provider of drug and alcohol treatment services, is rolling out the Intelligent Fingerprinting drug testing system across 50 of its UK sites to reduce the risk of Coronavirus infection for both service users and employees – while continuing national service provision. The fingerprint- based sweat drug test is non-invasive and hygienic, and supports the requirement for social distancing during testing. It takes less than a minute to collect a service user’s fingerprint sweat samples onto a small drug screening cartridge – and just ten minutes to analyse the cartridge and provide on-site results. The test screens for the opioid substitution drugs methadone and buprenorphine, as well as benzodiazepines and opiates. Change Grow Live already succe